WHO just dropped its first-ever guidelines for GLP-1 weight loss meds like Wegovy and Saxenda, and it’s a big deal. They’re saying these meds should be used long-term (not just for a quick fix) and always paired with healthy eating, movement, and counseling. But heads up: they’re not a magic bullet—obesity needs lifelong care. Biggest hurdles? High cost and limited access. Still, this feels like a major shift in how we treat obesity! #Fitness #WeightLoss #GLP1